天宇股份：关于为全资子公司申请追加银行综合授信并提供担保的公告

Group 1 - The company Tianyu Co., Ltd. announced on August 22 that it will hold the 14th meeting of the fifth board of directors on August 22, 2025, to review a proposal for additional bank credit for its wholly-owned subsidiary, Node Pharmaceutical [1] - The company plans to apply for an additional loan credit limit of 500 million yuan (approximately 70.5 million USD) from Industrial Bank to meet the funding needs for Node Pharmaceutical's new project, which aims to produce 6 billion solid dosage forms annually [1] - After the additional credit, Node Pharmaceutical will be able to apply for a total loan credit limit of up to 900 million yuan (approximately 126.8 million USD) from Industrial Bank, with a validity period of 10 years [1] Group 2 - The company will provide joint liability guarantee for this loan, and Node Pharmaceutical will use the land use rights of the project as collateral for the loan [1] - The board of directors is requested to authorize the company's chairman to handle the signing of agreements related to the credit limit, including but not limited to credit and loan matters [1]